Supernus Pharmaceuticals, Inc. (SUPN)

Supernus Pharmaceuticals Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Feb 11, 2026	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	2,944	1,997	1,581	1,928	1,551	1,326
Market Cap Growth	35.27%	26.29%	-18.00%	24.34%	16.99%	6.52%
Enterprise Value	2,710	1,632	1,398	1,849	1,128	1,019
Last Close Price	51.18	36.16	28.94	35.67	29.16	25.16
PE Ratio	-	27.03	1201.42	31.76	29.03	10.44
Forward PE	27.75	19.65	15.34	30.84	15.73	15.73
PS Ratio	4.20	3.02	2.60	2.89	2.68	2.55
PB Ratio	2.79	1.93	1.72	2.18	1.90	1.78
P/TBV Ratio	9.60	5.03	7.73	28.90	-	4.38
P/FCF Ratio	41.68	11.66	14.30	16.56	12.40	9.84
P/OCF Ratio	41.03	11.61	14.23	16.51	12.20	9.58
PEG Ratio	0.75	1.11	1.11	1.11	1.11	1.11
EV/Sales Ratio	3.98	2.47	2.30	2.77	1.95	1.96
EV/EBITDA Ratio	22.79	11.51	14.23	14.10	10.06	5.26
EV/EBIT Ratio	80.79	26.59	104.31	40.53	14.18	5.80
EV/FCF Ratio	38.31	9.53	12.65	15.88	9.01	7.56
Debt / Equity Ratio	0.04	0.03	0.05	0.51	0.54	0.59
Debt / EBITDA Ratio	0.32	0.22	0.37	3.13	3.55	2.17
Debt / FCF Ratio	0.60	0.20	0.38	3.87	3.52	3.24
Asset Turnover	0.49	0.50	0.41	0.39	0.36	0.39
Inventory Turnover	1.06	1.18	0.99	0.98	1.12	1.40
Quick Ratio	1.37	2.04	1.38	0.91	1.55	2.30
Current Ratio	1.80	2.35	1.70	1.07	1.91	2.57
Return on Equity (ROE)	-1.86%	7.55%	0.15%	7.13%	6.85%	18.94%
Return on Assets (ROA)	1.52%	2.90%	0.56%	1.68%	3.11%	8.24%
Return on Invested Capital (ROIC)	4.85%	6.99%	0.80%	5.09%	6.93%	18.77%
Return on Capital Employed (ROCE)	3.10%	5.70%	1.40%	4.50%	5.80%	13.90%
Earnings Yield	-0.65%	3.70%	0.08%	3.15%	3.45%	9.58%
FCF Yield	2.40%	8.58%	6.99%	6.04%	8.07%	10.16%
Buyback Yield / Dilution	-0.54%	-0.81%	10.01%	-13.47%	-1.24%	0.24%

Updated Nov 4, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q